Eptifibatid hæmmer trombocytaggregationen reversibelt ved at forebygge bindingen af fibrinogen, von - Willebrand faktor og andre adhæsive ligander til glykoprotein (GP) IIb/ IIIa- receptorer.
Eptifibatide reversibly inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor and other adhesive ligands to the glycoprotein (GP)IIb/ IIIa receptors.